Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year
Insulet Corporation (PODD)
Last insulet corporation earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insulet.com/investor-relations
Company Research
Source: Business Wire
Raising Full Year Revenue and Operating Margin Guidance ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced financial results for the three months ended March 31, 2024.First Quarter Financial Highlights:First quarter 2024 revenue of $441.7 million, up 23.3%, or 22.8% in constant currency1, compared to $358.1 million in the prior year, exceeds the guidance range of 17% to 20% in constant currency due to revenue outperformance for all product linesTotal Omnipod revenue of $433.0 million, an increase of 21.1%, or 20.5% in constant currencyU.S. Omnipod revenue of $317.7 million, an increase of 22.7%International Omnipod revenue of $115.3 million, an increase of 16.9%, or 14.8% in constant currencyDrug Delivery revenue of $8.7 millionGross margin of 69.5%, up 230 basis points, compared to gross margin of 67.2% in the prior year and up 460 bas
Show less
Read more
Impact Snapshot
Event Time:
PODD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PODD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PODD alerts
High impacting Insulet Corporation news events
Weekly update
A roundup of the hottest topics
PODD
News
- Will Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market [Yahoo! Finance]Yahoo! Finance
- Insulet (PODD) Q1 Earnings Top, 2024 Revenue View Raised [Yahoo! Finance]Yahoo! Finance
- Results: Insulet Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts [Yahoo! Finance]Yahoo! Finance
- Insulet Corporation (NASDAQ:PODD) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Canaccord Genuity Group Inc. from $226.00 to $234.00. They now have a "buy" rating on the stock.MarketBeat
PODD
Earnings
- 5/9/24 - Beat
PODD
Sec Filings
- 5/10/24 - Form 10-Q
- 5/9/24 - Form 8-K
- 5/2/24 - Form 4
- PODD's page on the SEC website